frequency
int64 1
472k
| HCPCS_Cd
stringlengths 5
5
| HCPCS_Desc
stringlengths 4
256
| rn
float64 1
1
|
|---|---|---|---|
33
|
J1459
|
Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg
| 1
|
12
|
J1556
|
Injection, immune globulin (bivigam), 500 mg
| 1
|
137
|
J1561
|
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
| 1
|
425
|
J1568
|
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
| 1
|
332
|
J1569
|
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
| 1
|
5
|
J1575
|
Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
| 1
|
4
|
J1599
|
Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg
| 1
|
862
|
J1602
|
Injection, golimumab, 1 mg, for intravenous use
| 1
|
93
|
J1610
|
Injection, glucagon hydrochloride, per 1 mg
| 1
|
63
|
J1627
|
Injection, granisetron, extended-release, 0.1 mg
| 1
|
11
|
J1738
|
Injection, meloxicam, 1 mg
| 1
|
53
|
J1930
|
Injection, lanreotide, 1 mg
| 1
|
3
|
J1950
|
Injection, leuprolide acetate (for depot suspension), per 3.75 mg
| 1
|
1
|
J1953
|
Injection, levetiracetam, 10 mg
| 1
|
219
|
J1955
|
Injection, levocarnitine, per 1 gm
| 1
|
702
|
J2001
|
Injection, lidocaine hcl for intravenous infusion, 10 mg
| 1
|
150
|
J2182
|
Injection, mepolizumab, 1 mg
| 1
|
24
|
J2185
|
Injection, meropenem, 100 mg
| 1
|
1,370
|
J2250
|
Injection, midazolam hydrochloride, per 1 mg
| 1
|
14
|
J2280
|
Injection, moxifloxacin, 100 mg
| 1
|
96
|
J2350
|
Injection, ocrelizumab, 1 mg
| 1
|
503
|
J2357
|
Injection, omalizumab, 5 mg
| 1
|
6
|
J2370
|
Injection, phenylephrine hcl, up to 1 ml
| 1
|
4
|
J2407
|
Injection, oritavancin (orbactiv), 10 mg
| 1
|
1
|
J2501
|
Injection, paricalcitol, 1 mcg
| 1
|
3
|
J2507
|
Injection, pegloticase, 1 mg
| 1
|
8
|
J2543
|
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)
| 1
|
15
|
J2545
|
Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg
| 1
|
3
|
J2562
|
Injection, plerixafor, 1 mg
| 1
|
499
|
J2704
|
Injection, propofol, 10 mg
| 1
|
23
|
J2720
|
Injection, protamine sulfate, per 10 mg
| 1
|
12
|
J2760
|
Injection, phentolamine mesylate, up to 5 mg
| 1
|
2
|
J2783
|
Injection, rasburicase, 0.5 mg
| 1
|
255
|
J2795
|
Injection, ropivacaine hydrochloride, 1 mg
| 1
|
1,010
|
J3010
|
Injection, fentanyl citrate, 0.1 mg
| 1
|
24
|
J3032
|
Injection, eptinezumab-jjmr, 1 mg
| 1
|
499
|
J3111
|
Injection, romosozumab-aqqg, 1 mg
| 1
|
91
|
J3145
|
Injection, testosterone undecanoate, 1 mg
| 1
|
9
|
J3241
|
Injection, teprotumumab-trbw, 10 mg
| 1
|
81
|
J3245
|
Injection, tildrakizumab, 1 mg
| 1
|
417
|
J3262
|
Injection, tocilizumab, 1 mg
| 1
|
34,205
|
J3301
|
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
| 1
|
1,294
|
J3304
|
Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
| 1
|
57
|
J3357
|
Ustekinumab, for subcutaneous injection, 1 mg
| 1
|
1
|
J3358
|
Ustekinumab, for intravenous injection, 1 mg
| 1
|
407
|
J3380
|
Injection, vedolizumab, 1 mg
| 1
|
284
|
J3411
|
Injection, thiamine hcl, 100 mg
| 1
|
298
|
J3415
|
Injection, pyridoxine hcl, 100 mg
| 1
|
5
|
J3473
|
Injection, hyaluronidase, recombinant, 1 usp unit
| 1
|
2,417
|
J3490
|
Unclassified drugs
| 1
|
3,097
|
J7030
|
Infusion, normal saline solution , 1000 cc
| 1
|
5
|
J7170
|
Injection, emicizumab-kxwh, 0.5 mg
| 1
|
2
|
J7187
|
Injection, von willebrand factor complex (humate-p), per iu vwf:rco
| 1
|
1
|
J7202
|
Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.
| 1
|
1
|
J7205
|
Injection, factor viii fc fusion protein (recombinant), per iu
| 1
|
506
|
J7312
|
Injection, dexamethasone, intravitreal implant, 0.1 mg
| 1
|
3
|
J7313
|
Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg
| 1
|
3
|
J7314
|
Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg
| 1
|
866
|
J7318
|
Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg
| 1
|
1,200
|
J7320
|
Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg
| 1
|
667
|
J7322
|
Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg
| 1
|
2,095
|
J7326
|
Hyaluronan or derivative, gel-one, for intra-articular injection, per dose
| 1
|
970
|
J7327
|
Hyaluronan or derivative, monovisc, for intra-articular injection, per dose
| 1
|
738
|
J7328
|
Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg
| 1
|
106
|
J7329
|
Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg
| 1
|
192
|
J7332
|
Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg
| 1
|
29
|
J7333
|
Hyaluronan or derivative, visco-3, for intra-articular injection, per dose
| 1
|
9
|
J7336
|
Capsaicin 8% patch, per square centimeter
| 1
|
631
|
J7345
|
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
| 1
|
144
|
J7351
|
Injection, bimatoprost, intracameral implant, 1 microgram
| 1
|
1,234
|
J7999
|
Compounded drug, not otherwise classified
| 1
|
53
|
J9022
|
Injection, atezolizumab, 10 mg
| 1
|
895
|
J9030
|
Bcg live intravesical instillation, 1 mg
| 1
|
10
|
J9034
|
Injection, bendamustine hcl (bendeka), 1 mg
| 1
|
2
|
J9040
|
Injection, bleomycin sulfate, 15 units
| 1
|
5
|
J9043
|
Injection, cabazitaxel, 1 mg
| 1
|
2
|
J9044
|
Injection, bortezomib, not otherwise specified, 0.1 mg
| 1
|
190
|
J9144
|
Injection, daratumumab, 10 mg and hyaluronidase-fihj
| 1
|
74
|
J9145
|
Injection, daratumumab, 10 mg
| 1
|
26
|
J9173
|
Injection, durvalumab, 10 mg
| 1
|
1
|
J9176
|
Injection, elotuzumab, 1 mg
| 1
|
1
|
J9185
|
Injection, fludarabine phosphate, 50 mg
| 1
|
1,396
|
J9190
|
Injection, fluorouracil, 500 mg
| 1
|
3
|
J9198
|
Injection, gemcitabine hydrochloride, (infugem), 100 mg
| 1
|
199
|
J9206
|
Injection, irinotecan, 20 mg
| 1
|
7
|
J9214
|
Injection, interferon, alfa-2b, recombinant, 1 million units
| 1
|
2
|
J9227
|
Injection, isatuximab-irfc, 10 mg
| 1
|
10
|
J9228
|
Injection, ipilimumab, 1 mg
| 1
|
1
|
J9230
|
Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg
| 1
|
70
|
J9260
|
Methotrexate sodium, 50 mg
| 1
|
578
|
J9263
|
Injection, oxaliplatin, 0.5 mg
| 1
|
1,548
|
J9271
|
Injection, pembrolizumab, 1 mg
| 1
|
470
|
J9299
|
Injection, nivolumab, 1 mg
| 1
|
2
|
J9301
|
Injection, obinutuzumab, 10 mg
| 1
|
5
|
J9306
|
Injection, pertuzumab, 1 mg
| 1
|
17
|
J9311
|
Injection, rituximab 10 mg and hyaluronidase
| 1
|
500
|
J9312
|
Injection, rituximab, 10 mg
| 1
|
1
|
J9352
|
Injection, trabectedin, 0.1 mg
| 1
|
313
|
J9395
|
Injection, fulvestrant, 25 mg
| 1
|
2
|
K0739
|
Repair or nonroutine service for durable medical equipment other than oxygen equipment requiring the skill of a technician, labor component, per 15 minutes
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.